Cargando…
Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data
This study aimed at producing an updated assessment of the incidence of anaphylaxis associated with COVID-19 vaccines based on pharmacovigilance data. Anaphylactic reaction and anaphylactic shock data post-COVID-19-vaccination reported from week 52, 2020 to week 1 or week 2, 2023 were collected from...
Autores principales: | Boufidou, Fotini, Hatziantoniou, Sophia, Theodoridou, Kalliopi, Maltezou, Helena C., Vasileiou, Konstantinos, Anastassopoulou, Cleo, Medić, Snežana, Tsakris, Athanasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051410/ https://www.ncbi.nlm.nih.gov/pubmed/36992197 http://dx.doi.org/10.3390/vaccines11030613 |
Ejemplares similares
-
Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study
por: Hatziantoniou, Sophia, et al.
Publicado: (2021) -
Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance
por: Maltezou, Helena C., et al.
Publicado: (2023) -
The Role of Oral Antivirals for COVID-19 Treatment in Shaping the Pandemic Landscape
por: Anastassopoulou, Cleo, et al.
Publicado: (2022) -
SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic
por: Boufidou, Fotini, et al.
Publicado: (2023) -
Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines
por: Maltezou, Helena C., et al.
Publicado: (2022)